Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure

https://doi.org/10.1016/0002-9149(89)90652-8Get rights and content

Abstract

A new clinical index of dyspnea and fatigue has been applied to rate the condition of patients with congestive heart failure. The index has 3 components, each rated on a scale from 0 to 4, for the magnitude of the task that evokes dyspnea or fatigue, the magnitude of the pace (or effort) with which the task is performed and the associated functional impairment in general activities. The ratings for each component are added to form an aggregated score, which can range from 0, for the worst condition, to 12, for the best. Because dyspnea and fatigue are prime symptoms and sources of clinical distress, the index helps reflect the quality of life in patients with congestive heart failure. In double-blind trials of therapy, changes in the index showed good correlations with patients' self-selected ratings of improvement. The posttherapeutic changes in the index ratings were significantly higher with a new active agent (lisinopril) than with placebo or another active agent (captopril).

References (31)

  • TJ Ryan

    Cardiology 1982. ‘Whither are we tending and what ought our aim to be?’

    Circulation

    (1986)
  • WO Spitzer et al.

    Measuring the quality of life of cancer patients. A concise QL-index for use by physicians

    J Chronic Dis

    (1981)
  • RF Meenan et al.

    Measuring the quality of life of cancer patients

    J Chronic Dis

    (1981)
  • Cited by (0)

    This study was supported in part by grant 81-24 from the Commonwealth Fund, New York, New York, and a grant from the Andrew W. Mellon Foundation, New York.

    1

    Dr. Pigeon's present address: Department of Mathematical Science, Villanova University, Villanova, Pennsylvania.

    View full text